Back
Day Range
$7.45
$8.35
52-Week Range
$1.83
$12.43
Volume
28,667,785
50D / 200D Avg
$7.10
/
$3.63
Prev Close
$7.42
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (631 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -23.6 | 0.3 |
| P/B | — | 3.0 |
| ROE % | — | 3.7 |
| Net Margin % | -310.2 | 3.8 |
| Rev Growth 5Y % | 231.9 | 10.0 |
| D/E | — | 0.2 |
Analyst Price Target
Hold
$13.50
+67.3%
Low: $12.00
High: $15.00
Forward EPS
-$0.26
Est. Revenue
209.46M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$1.96
$1.20 – $2.92
|
3.69B | 1 |
| FY2029 |
$1.09
$0.67 – $1.62
|
2.18B | 1 |
| FY2028 |
$0.51
$0.40 – $0.60
|
1.21B | 3 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-23 | -$0.08 | -$0.06 | +25.0% |
| 2025-11-04 | -$0.10 | -$0.07 | +30.0% |
| 2025-08-05 | -$0.10 | -$0.10 | 0.0% |
| 2025-05-12 | -$0.12 | -$0.15 | -25.0% |
| 2025-03-03 | -$0.26 | -$0.15 | +42.3% |
| 2024-11-12 | -$0.18 | -$0.14 | +22.2% |
| 2024-08-12 | -$0.17 | -$0.20 | -17.6% |
| 2024-05-09 | -$0.16 | -$0.20 | -25.0% |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Key Takeaways
Revenue grew 231.86% annually over 5 years — strong growth
Negative free cash flow of -308.78M
PEG of 0.15 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 436.45%
Capital efficient — spends only 3.39% of revenue on capex
Growth
Revenue Growth (5Y)
231.86%
Revenue (1Y)668.31%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
N/A
ROIC-50.73%
Net Margin-310.18%
Op. Margin-226.00%
Safety
Debt / Equity
N/A
Current Ratio5.10
Interest Coverage-2.28
Valuation
P/E Ratio
-23.61
Forward P/EN/A
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 668.31% | Revenue Growth (3Y) | 1249.57% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 231.86% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 113.29M | Net Income (TTM) | -351.40M |
| ROE | N/A | ROA | -70.01% |
| Gross Margin | 99.34% | Operating Margin | -226.00% |
| Net Margin | -310.18% | Free Cash Flow (TTM) | -308.78M |
| ROIC | -50.73% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 5.10 |
| Interest Coverage | -2.28 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -23.61 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | 73.24 |
| PEG Ratio | 0.15 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 39.61 | Fwd Earnings Yield | N/A |
| FCF Yield | -3.72% | ||
| Market Cap | 8.30B | Enterprise Value | 9.09B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 113.29M | 14.75M | 622,000.0 | 240,000.0 | 934,000.0 |
| Net Income | -351.40M | -413.56M | -583.20M | -416.57M | -346.79M |
| EPS (Diluted) | -0.38 | -0.62 | -1.15 | -1.04 | -0.89 |
| Gross Profit | 112.54M | 14.75M | 622,000.0 | 240,000.0 | 934,000.0 |
| Operating Income | -256.03M | -344.18M | -362.25M | -351.30M | -330.28M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 501.90M | 382.93M | 504.45M | 362.36M | 468.91M |
| Total Liabilities | 1.00B | 871.06M | 1.09B | 812.18M | 712.82M |
| Shareholders' Equity | -499.57M | -489.10M | -586.99M | -447.33M | -242.17M |
| Total Debt | 878.12M | 504.17M | 726.72M | 723.77M | 645.66M |
| Cash & Equivalents | 88.33M | 143.43M | 265.45M | 104.64M | 181.10M |
| Current Assets | 314.88M | 184.59M | 294.08M | 140.58M | 334.35M |
| Current Liabilities | 61.75M | 54.94M | 58.28M | 500.86M | 369.00M |